| 1 |
35154579 | ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells. | 2022 |
1 |
| 2 |
34319043 | MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells. | 2021 Jul 1 |
3 |
| 3 |
25804768 | The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine. | 2015 |
1 |
| 4 |
24495868 | A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine. | 2014 Jan 30 |
1 |
| 5 |
25111583 | Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FMS-like tyrosine kinase 3 internal tandem duplications-positive acute myeloid leukemia cells. | 2014 Nov |
2 |
| 6 |
23681223 | BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells. | 2013 May 16 |
1 |
| 7 |
24141622 | Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B. | 2013 Oct 18 |
1 |
| 8 |
22072733 | Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells. | 2012 Jan 15 |
1 |
| 9 |
22128299 | Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia. | 2012 Jan 15 |
1 |
| 10 |
22619113 | The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells. | 2012 May |
1 |
| 11 |
21750559 | Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. | 2011 Jul 12 |
1 |
| 12 |
20335218 | Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. | 2010 Jun 3 |
1 |
| 13 |
18836097 | AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. | 2009 Jan 1 |
1 |
| 14 |
19008456 | Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab. | 2009 Jan 15 |
1 |
| 15 |
19762485 | Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. | 2009 Nov 12 |
1 |
| 16 |
18599795 | Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. | 2008 Nov 1 |
2 |
| 17 |
16501812 | Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins. | 2006 Mar |
2 |
| 18 |
17018621 | Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA. | 2006 Oct 1 |
1 |
| 19 |
15059916 | The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells. | 2004 Apr 1 |
1 |
| 20 |
11472347 | Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia. | 2001 Jul |
1 |
| 21 |
9558396 | Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. | 1998 May 1 |
1 |